TrialEuropean journal of haematology2026

Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.

Ruben Jara Rubio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.